With the rapid development of medical science and technology, the R&D process of new drugs is increasingly demanding in terms of efficiency, accuracy and cost. Against this backdrop, the InnoModels Biotechnology PDC platform has emerged to revolutionize the field of new drug discovery and development with its unique technological advantages. In this paper, we will introduce the features of the InnoModels Biotechnology PDC high-throughput in vitro drug efficacy platform in detail, in order to reveal its important value in drug research.
1、Highly consistent primary cell support
Using the digestion products of the PDX model, the PDC high-throughput in vitro drug efficacy platform of InnoModels Biotechnology has successfully obtained highly consistent primary cells with patients. These cells not only have complex cell subpopulations and biological characteristics, but are also able to more closely mimic drug actions and responses in clinical situations. This provides researchers with valuable experimental materials, making the results of drug development more meaningful.
2、Efficient prediction of drug clinical efficacy
The platform can not only be used for the screening of test drugs and models, but also can predict the clinical effectiveness of drugs. By comparing the efficacy response of the subject drug with that of a standard drug (e.g., a drug with a similar mechanism of action or a standardized therapeutic drug), the researcher is able to more accurately assess the clinical value of the drug. This predictive ability helps to reduce blindness in the drug development process and improve the success rate.
3、Significant Experimental Efficiency and Cost Advantages
Compared with the traditional in vivo experimental platform, InnoModels' PDC high-throughput in vitro drug efficacy platform has a significant experimental cycle advantage. The in vitro experimental platform can shorten the experimental cycle by more than three times, and at the same time, the flux of the tested drugs can be increased by more than five times. What's more, the cost of the platform is only a fraction of that of in vivo experiments. This enables researchers to accomplish more drug screening and efficacy testing within limited time and budget, improving R&D efficiency.

4、Multi-parameter assay and multi-cell type support
PDC technology allows researchers to simultaneously assess multiple cell phenotypic parameters, such as cell proliferation, cell cycle, apoptosis, etc., providing a more comprehensive understanding of drug effects. In addition, the technology supports the application of multiple cell types, including tumor cells, primary cells, etc., for drug research in different disease areas. This flexibility allows the InnoModels Biotechnology PDC high-throughput in vitro drug efficacy platform to meet a wider range of research needs.
5、High-throughput Screening and Customized Service
The platform is equipped with high-throughput screening capabilities, enabling rapid screening of a large number of drugs in a short period of time. This not only improves research efficiency, but also provides strong support for efficient drug discovery. In addition, InnoModels Biotechnology also provides customized services to tailor the experimental protocols according to the specific needs of the researcher, ensuring the accuracy and reliability of the experimental results.
Summary:
With its highly consistent primary cell support, efficient prediction of drug clinical effectiveness, significant experimental efficiency and cost advantages, multi-parameter assay and multi-cell type support, as well as high-throughput screening and customized services, the PDC high-throughput in vitro efficacy platform from InnoModels Biotechnology has revolutionized the field of new drug discovery and development. The emergence of this platform will strongly promote the process of new drug R&D, accelerate the pace of drug launch, and make important contributions to human health.